Clinical Trials Directory

Trials / Completed

CompletedNCT03775681

Feasibility of Laryngeal Mask Airway Gastro on Patients Undergoing Endoscopic Retrograde Cholangiopancreatography for Pancreas and Bile Duct Disorders

Is the Gastro LMA a Feasible Alternative to the Use of a Native Airway for Endoscopic Retrograde Cholangiopancreatography (ERCP) Cases?

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
33 (actual)
Sponsor
M.D. Anderson Cancer Center · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This trial determines the feasibility of Laryngeal Mask Airway Gastro (Laryngeal Mask Airway) when used on patients who are undergoing endoscopic retrograde cholangiopancreatography for pancreas and bile duct disorders. Laryngeal Mask Airway is a device that helps patients breathe while they are asleep during procedures.

Detailed description

PRIMARY OBJECTIVES: I. To determine the successful completion of endoscopic retrograde cholangiopancreatography (ERCP) with the Laryngeal Mask Airway (LMA) Gastro. SECONDARY OBJECTIVES: I. To determine gastroenterologist satisfaction with the LMA Gastro. II. To determine anesthesia provider satisfaction with the LMA Gastro. III. To determine the rate of unsuccessful LMA Gastro placement. IV. To determine the ability of LMA Gastro to provide adequate oxygenation and ventilation throughout the procedure. V. To determine and describe the rate of adverse events. OUTLINE: Patients wear Laryngeal Mask Airway Gastro after receiving general anesthesia and falling asleep. Patients then undergo standard of care endoscopic retrograde cholangiopancreatography. Patients also complete a 5-minute interview following ERCP procedure.

Conditions

Interventions

TypeNameDescription
PROCEDUREEndoscopic Retrograde CholangiopancreatographyUndergo standard of care ERCP
OTHERInterviewAncillary studies
DEVICELaryngeal Mask AirwayWear LMA

Timeline

Start date
2019-01-16
Primary completion
2020-04-20
Completion
2020-04-20
First posted
2018-12-14
Last updated
2021-04-27
Results posted
2021-04-27

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT03775681. Inclusion in this directory is not an endorsement.